An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis
The study is a prospective, observational, multicenter clinical trial to be conducted in the
internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After
obtaining informed consent from the patient, the investigator will perform an inclusion visit
made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM
CoV2.
Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study
participants will be diagnosed with COVID-19 positive during the study period, the attending
physician is entitled to decide on their management based on the severity of the clinical
status.
Diagnostic Test: Serological test
Positive serological test of SARS Cov2
Inclusion Criteria:
- Age over 18 years old
- One of the following conditions: systemic lupus, Sjögren's syndrome, rheumatoid
arthritis, inflammatory myopathies, spondyloarthritis, sarcoidosis and Behçet's
disease.
- Informed consent obtained and signed
Exclusion Criteria:
- Refusal to repeat blood sampling if the first one was badly performed
- Informed consent not obained
Military Hospital of Tunis
Tunis, Tunisia
Investigator: Faida Ajili, MD
Contact: +21698631188
faida1977@yahoo.fr
Investigator:
Faida Ajili, MD
+21698631188
faida1977@yahoo.fr
Faida Ajili, MD, Study Chair
Military Hospital of Tunis